GE HealthCare and Stryker Report Third Quarter Sales Growth

GE HealthCare raised its full-year organic revenue growth outlook to about 4%, while Stryker forecasts 6.5%–7% organic sales growth.

Daniel Beaird

Nov. 6, 2026

Add Us On Google

Key Highlights

GE HealthCare reported $5.5 billion in revenue, up 7.2% year over year, with organic orders rising 4% and backlog reaching $23.7 billion.
GE HealthCare raised its full-year organic revenue growth target to approximately 4%, citing volume, pricing, productivity, and a favorable tariff comparison as margin supports.
Stryker reported $6.5 billion in quarterly sales, up 7.7% on both reported and organic bases, led by 9.1% growth in MedSurg and Neurotechnology.
Stryker’s CEO said results fell short of expectations; the company set a full-year organic sales growth outlook of 6.5%–7%, including a modest pricing contribution.
The results point to continued supplier demand, while pricing remains relevant to both healthcare purchasing costs and company performance.

GE HealthCare and Stryker reported third quarter sales growth across their businesses, offering evidence of continued demand for medical equipment and procedural products, although performance did not uniformly meet company expectations.

GE HealthCare reported revenue of $5.5 billion, up 7.2% from a year earlier, including 6.2% organic growth. Organic orders increased 4%, and backlog totaled $23.7 billion. The company raised its full-year outlook, targeting approximately 4% organic revenue growth. Volume, pricing, productivity, and a favorable year-over-year net tariff impact supported margin improvement, partially offset by inflation.

Stryker reported quarterly sales of $6.5 billion, up 7.7% on both a reported and organic basis. Organic sales increased 9.1% in MedSurg and Neurotechnology and 5.9% in Orthopaedics, primarily reflecting higher unit volume. Despite that growth, Chairman and CEO Kevin Lobo said overall performance fell short of the company’s expectations. Stryker updated its full-year organic sales growth outlook to 6.5%–7%, including a modest positive pricing contribution.

For healthcare purchasing leaders, the results suggest continued demand in these suppliers’ portfolios alongside ongoing price pressure. GE HealthCare identified pricing as one contributor to improved margins, while Stryker expects pricing to support annual growth.